|
See related Renagel film-coated tab information |
|
|
|
Manufacturer |
Genzyme |
|
Distributor |
Hong Kong: LF Asia/Macau: Four Star |
|
Contents |
Sevelamer HCl |
|
Indications |
Reduction of serum phosphorus in patients w/ end-stage renal disease (ESRD). |
|
Dosage |
Patients not taking a phosphate binder Initially 800-1600 mg. Dose adjusted based on serum phosphorus conc. |
|
Administration |
Should be taken with food (Swallow whole, do not chew/crush.). |
|
Contraindications |
Hypophosphatemia or bowel obstruction. |
|
Special Precautions |
Dysphagia, swallowing disorders, severe GI motility disorder or major GIT surgery. Patients on antiarrhythmic & antiseizure drugs. Pregnancy & lactation. |
|
Adverse Drug Reactions |
Headache, infection, pain; HTN, hypotension, thrombosis; diarrhea, dyspepsia, vomiting; increased cough.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
ATC Classification |
V03AE02 - sevelamer ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Renagel film-coated tablet |
|
Renagel 400 mg x 360's |
|
Renagel 800 mg x 180's |
|
|
|
Manufacturer: |
Genzyme |
|
Distributor: |
Hong Kong: LF Asia
Macau: Four Star |
|
Marketer: |
Kyowa Hakko Kirin |
|
 |
|
|
|
